Description
In today's modern lifestyle, factors like poor sleep habits, lack of exercise, smoking, unbalanced diet, along with environmental pollution and genetic predisposition can significantly increase cancer risks. Our MYGENIA® Circulating Tumor DNA (ctDNA) Cancer Risk Assessment employs advanced DNA sequencing technology to screen 270 cancer-related genes, covering up to 38-42 common cancers in a single test. By detecting potential cancer risks early through ctDNA analysis, you can take proactive preventive measures. Schedule your assessment today to safeguard your health future with our comprehensive genetic screening and professional medical guidance!
MYGENIA® Circulating Tumor DNA (ctDNA) Cancer Risk Assessment (Upgraded)
HOW CANCER STARTS?
- For a cancer to start, changes take place within the genes of a cell or a group of cells
- It can take many years for a cell to divide and accumulate enough mutations to form a tumor
- Cancer is the leading cause of death in Hong Kong and mainland China, and its incidence and mortality are increasing
- Before the age of 75:
Almost 1 in 4 will attain cancer
Almost 1 in 12 will die cancer
OVER 50% CANCER CASES ARE DIAGNOSED AT LATE-STAGES OF THE DISEASES
- Over 34,000 people are diagnosed with cancer each year in Hong Kong
- Over 50% of cancer cases are diagnosed late
- Mirroring incidence trends, rates increased for cancers in younger individuals
SCREENING CTDNA IS A BETTER WAY FOR EARLY CANCER RISK ASSESSMENT
- ctDNA is released from the tumor cell, which is dead or active, and then enters the blood.
- As ctDNA comes from tumor cells, this is a significant biomarker for early cancer risk assessment.
- For cancer risk assessment, we are screening the ctDNA, which has any gene mutations.
MYGENIA® CIRCULATING TUMOR DNA (CTDNA) CANCER RISK ASSESSMENT
- Interrogating 270 cancer-related genes in a single test
- Comprehensively covering 38 and 42 common cancer-related diseases in males and females respectively
- The latest OEC detection technology interrogates all the coding regions of the target genes
- OEC detection technology covers more gene mutations related to cancer pathogenesis
NEW COLLECT SAMPLING METHOD – MORE CONVENIENT
SUITABLE FOR:
- Unhealthy lifestyle: staying up late and sleep deprivation
- Overweight, lack of exercise
- Smoking, drinking alcohol and other unhealthy diet
- Staying in highly polluted or radiologically contaminated places
- Persons with non-communicable diseases or immunocompromised conditions
- Persons with family history of cancer
Source:
* Hong Kong Anti-Cancer Society
# HKCaR
Instructions for use：
- Must be used on or before the expiration date
- Please show your confirmation information, order number, registered full name and phone number for verification
Terms and Conditions：
- This voucher is only valid for Trinity Medical Centre.
- The voucher must be paid on or before 30 June 2024, can be used at Central , Causeway Bay or Tsim Sha Tsui Trinity Medical Centre.
- This voucher must be used within 90 days after purchase and this voucher is not valid after expiration.
- This voucher is non-refundable and cannot be redeemed for full or partial cash.
- You must bring this ticket to the front desk when you register.
- This voucher cannot be used with any other special offers and promotions.
- If this voucher is lost or stolen, we will not accept any liability and will not provide any reissue in such case.
- If you have any questions, please call 2192 7022 or email tmc@trinitymedical.com.hk
- Trinity Medical Centre reserves the right to amend the above Terms and Conditions without prior notice. In case of any disputes, Trinity Medical Centre reserves all rights for final decision.
